Zealand Pharma a/S – Filings and Transcripts – BamSEC

You must log in to view this page.

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/21 FY 2021 – amended

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020 – amended

ended 12/31/20 FY 2020 – amended

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Securities registration termination

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Removal from listing

Registration of securities for employees

Ownership Filter

Van Herk Investments B.V.

Wellington Management Group Llp

Van Herk Investments B.V.

Van Herk Investments B.V.

Wellington Management Group Llp

News Filter

Announces Global License and Development Agreement With Novo Nordisk for ZEGALOGUE®

Total Number of Shares and Voting Rights in Zealand Pharma at August 31, 2022

Appoints Henriette Wennicke as Chief Financial Officer

Company Announcement – No. 32/ 2022

Launches Long-Term Incentive Program for Zealand’s Corporate Management and Employees for 2022

Proxies

No filings in this category.

Other Filter

Confidential treatment order

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness